The University of Chicago Header Logo

Connection

James Liao to Anticholesteremic Agents

This is a "connection" page, showing publications James Liao has written about Anticholesteremic Agents.
Connection Strength

1.352
  1. Squalene synthase inhibitor lapaquistat acetate: could anything be better than statins? Circulation. 2011 May 10; 123(18):1925-8.
    View in: PubMed
    Score: 0.361
  2. Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Circulation. 2009 Jan 06; 119(1):131-8.
    View in: PubMed
    Score: 0.307
  3. Statin therapy: having the good without the bad. Hypertension. 2004 Jun; 43(6):1171-2.
    View in: PubMed
    Score: 0.224
  4. Lipid management with statins. The lower the better? Z Kardiol. 2004 Jan; 93(1):4-9.
    View in: PubMed
    Score: 0.218
  5. Endothelium-dependent effects of statins. Arterioscler Thromb Vasc Biol. 2003 May 01; 23(5):729-36.
    View in: PubMed
    Score: 0.205
  6. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci U S A. 1998 Jul 21; 95(15):8880-5.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.